India’s Gennova working on Omicron-specific COVID-19 vaccine – source
New Delhi (Reuters) - India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or...
Expect more worrisome variants after omicron, scientists say
Boston (AP) - Get ready to learn more Greek letters. Scientists warn that omicron’s whirlwind advance practically ensures it won’t be the last version...
Conspiracy theorists lack critical thinking skills: New study
by John Elder
Teaching analytical thinking can reduce or protect against the adoption of conspiracy theories.
The more people believe in conspiracy theories, the worse they...
Indonesia survey finds 85% of population have COVID-19 antibodies
Jakarta (Reuters) - More than 85% of Indonesia's population has antibodies against COVID-19, a government-commissioned survey showed, but epidemiologists warned it was not...
Hair loss treatment for votes? S.Korea’s hairy debate
Seoul (Reuters) - South Korea's ruling party presidential candidate ignited a debate this week after he proposed allowing public healthcare insurance to cover...